Trabectedin: all 72 studies that test it
Page 1 of 1. Open to participants first (10), then studies with results posted, then the rest; newest registration first within each.
- A Phase I Study of Pazopanib in Combination With Trabectedin, Ipilimumab and Nivolumab (TraPIN) in Pediatric and Young Adult Patients With Recurrent Soft Tissue SarcomasRecruitingNCT07444619Phase 1
- Phase II Decentralized Pragmatic Trial of Adjuvant Doxorubicin - Trabectedin Chemotherapy in uLMSRecruitingNCT07076186Phase 2
- Interest of Post-operative Chemotherapy in Patients With Localised Uterine Leiomyosarcoma Suspected of Having a High Risk of Recurrence Based on a Biological Test Performed on the TumourRecruitingNCT06524583Phase 2
- Multicohort Trial of Trabectedin and Low-dose Radiation Therapy in Advanced/Metastatic SarcomasRecruitingNCT05131386Phase 2
- Metronomic Trabectedin, Gemcitabine, and Dacarbazine for Soft Tissue SarcomaRecruitingNCT04535271Phase 2
- Trial in Patients With Metastatic or Locally Advanced LeiomyosarcomaRecruitingNCT04383119Phase 2
- Study on Trabectedin in Advanced Rearranged Mesenchymal ChondrosarcomaRecruitingNCT04305548Phase 2
- Talimogene Laherparepvec, Nivolumab and Trabectedin for SarcomaRecruitingNCT03886311Phase 2
- SAINT:Trabectedin, Ipilimumab and Nivolumab for Previously Treated Advanced Soft Tissue SarcomaRecruitingNCT03138161Phase 1/2
- Trabectedin Plus Radiotherapy in Soft Tissue Sarcoma PatientsRecruitingNCT02275286Phase 1/2
- Trabectedin in Combination With Olaparib in Advanced Unresectable or Metastatic SarcomaCompletedNCT04076579Phase 2Results posted
- QoL-Comparison Between Trabectedin/PLD and Pt-based Therapy in Patients With Pt-sensitive Recurrent Ovarian CancerTerminatedNCT03164980Phase 4Results posted
- Avelumab and Trabectedin in Treating Patients With Liposarcoma or Leiomyosarcoma That is Metastatic or Cannot Be Removed by SurgeryTerminatedNCT03074318Phase 1/2Results posted
- Targeting Microenvironment and Cellular Immunity in Sarcomas Weekly Trabectedin Combined With Metronomic CyclophosphamideCompletedNCT02805725Phase 1/2Results posted
- Trabectedin for Recurrent Grade II/III MeningiomaCompletedNCT02234050Phase 2Results posted
- A Study Comparing the Combination of Trabectedin (YONDELIS) and DOXIL/CAELYX With DOXIL/CAELYX for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube CancerCompletedNCT01846611Phase 3Results posted
- A Study of Trabectedin or Dacarbazine for the Treatment of Patients With Advanced Liposarcoma or LeiomyosarcomaCompletedNCT01343277Phase 3Results posted
- An Efficacy and Safety Study of Trabectedin Versus Doxorubicin-Based Chemotherapy in Participants With Translocation-Related Sarcomas (TRS)CompletedNCT00796120Phase 3Results posted
- A Study to Assess the Potential Effects of a Single-Dose Administration of Trabectedin on the QT Intervals of the ElectrocardiogramCompletedNCT00786838Phase 2Results posted
- Safety and Efficacy Study of Trabectedin for the Treatment of Localized Myxoid / Round Cell LiposarcomaCompletedNCT00579501Phase 2Results posted
- Docetaxel, Trabectedin, and G-CSF or Pegfilgrastim in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube CancerCompletedNCT00569673Phase 2Results posted
- Trabectedin in Treating Patients With Advanced, Persistent, or Recurrent Leiomyosarcoma of the UterusCompletedNCT00379145Phase 2Results posted
- ET 743 (Yondelis) in Men With Advanced Prostate CancerCompletedNCT00147212Phase 2Results posted
- An Efficacy and Safety Study for Yondelis (Trabectedin) in Patients With Advanced Relapsed Ovarian CancerCompletedNCT00113607Phase 3Results posted
- Trabectedin in Treating Young Patients With Recurrent or Refractory Soft Tissue Sarcoma or Ewing's Family of TumorsCompletedNCT00070109Phase 2Results posted
- A Study to Assess Treatment With 2 Different Dosing Schedules of Trabectidin Administered to Patients With Advanced CancerCompletedNCT00060944Phase 2Results posted
- Study on Trabectedin in Combination With Pioglitazone in Patients Myxoid Liposarcomas With Stable Disease After T Alone.CompletedNCT04794127Phase 2
- Prospective Identification of Predictive Biomarkers of Trabectedin Efficacy in Non-L Soft-tissue Sarcoma PatientsCompletedNCT04008238Not applicable
- Olaratumab Plus Trabectedin in Advanced Soft-tissue Sarcoma Patients Soft-tissue Sarcoma PatientsActive, not recruitingNCT03985722Phase 1
- Trabectedin and Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Resistant or Intolerant to a BTK InhibitorWithdrawnNCT03884972Phase 1
- Randomized Trial in Advanced, Metastatic or Unresectable Soft Tissue Sarcoma After Failure of Standard Treatments.CompletedNCT03838744Phase 2
- Evaluation of Symptom Benefit Rate of Trabectedin/PLD in Patients With Recurrent Ovarian CancerTerminatedNCT03690739Phase 3
- Combined Treatment With Nivolumab and Trabectedin in Patients With Metastatic or Inoperable Soft Tissue SarcomasCompletedNCT03590210Phase 2
- Trabectedin, Doxorubicin and Olaratumab in Patients With Metastatic or Recurrent LeiomyosarcomaWithdrawnNCT03437070Phase 1
- Immune Changes Following Trabectedin in Patients With Metastatic or Unresectable SarcomaWithdrawnNCT03397186Phase 2
- Study of Olaparib/Trabectedin vs. Doctor's Choice in Solid TumorsCompletedNCT03127215Phase 2
- Study With Trabectedin Versus Adriamycin Plus Dacarbazine, in Patients With Advanced Solitary Fibrous TumorCompletedNCT03023124Phase 2
- Study Comparing Efficacy of Doxorubicin With Trabectedin Followed by Trabectedin Versus Doxorubicine in Patients With LeiomyosarcomaCompletedNCT02997358Phase 3
- Trial On Trabectedin In The Treatment Of Advanced Uterine And Ovarian Carcinosarcoma (CS)CompletedNCT02993705Phase 2
- Trabectedin Maintenance Post 1st-line in STSTerminatedNCT02929394Phase 3
- Trial on Trabectedin (ET-743) vs Clinician's Choice Chemotherapy in Recurrent Ovarian, Primary Peritoneal or Fallopian Tube Cancers of BRCA Mutated or BRCAness Phenotype PatientsCompletedNCT02903004Phase 3
- Trial Comparing Trabectedin to the Best Supportive Care in Patients With SarcomaCompletedNCT02672527Phase 3
- Trabectedin Plus Olaparib in Metastatic or Advanced Sarcomas (TOMAS)CompletedNCT02398058Phase 1
- Hyper-Thermia Enhanced Anti-tumor Efficacy of TrabectedinStatus unknownNCT02359474Phase 2
- Activity of Trabectedin or Gemcitabine + Docetaxel in Uterine LeiomyosarcomaCompletedNCT02249702Phase 2
- Efficacy Study on Trabectedin in Retroperitoneal Leiomyosarcoma and Well Differentiated/Dedifferentiated LiposarcomaCompletedNCT02247544Phase 2
- ATREUS - Phase II Study on the Activity of Trabectedin in Patients With Malignant Pleural Mesothelioma (MPM)CompletedNCT02194231Phase 2
- Study of Doxorubicin and Trabectedin in First Line Treatment on Patients With Metastatic LeiomyosarcomaCompletedNCT02131480Phase 2
- Trabectedin First Line Therapy In Unfit Sarcoma StudyCompletedNCT02066675Phase 2
- Study With Trabectedin in BRCA1 and BRCA2 Mutation Carrier and BRCAness Phenotype Ovarian CancerStatus unknownNCT01772979Phase 2
- Bevacizumab and Trabectedin +/- Carboplatin in Advanced Ovarian CancerCompletedNCT01735071Phase 2
- Localized High-Risk Soft Tissue Sarcomas Of The Extremities And Trunk Wall In Adults: An Integrating Approach Comprising Standard Vs Histotype-Tailored Neoadjuvant ChemotherapyCompletedNCT01710176Phase 3
- A Study of Trabectedin (YONDELIS) in Patients With Locally Advanced or Metastatic Liposarcoma or LeiomyosarcomaCompletedNCT01692678Phase 3
- Combination Therapy of Gemcitabine and Trabectedin in L-sarcomasCompletedNCT01426633Phase 1
- INOVATYON STUDY -International, Randomized Study in Patients With Ovarian CancerCompletedNCT01379989Phase 3
- Trabectedin in Treating Patients With Metastatic Pancreatic Cancer After First-Line ChemotherapyCompletedNCT01339754Phase 2
- Continuing vs Intermittent Trabectedin in Patients With Advanced Soft Tissue SarcomaCompletedNCT01303094Phase 2
- A Pharmacokinetic Study of Trabectedin in Patients With Advanced Malignancies and Hepatic DysfunctionCompletedNCT01273493Phase 1
- A Study to Assess the Potential Effects of Ketoconazole on the Pharmacokinetics of Trabectedin in Patients With Advanced MalignanciesCompletedNCT01267084Phase 1/2
- Doxorubicin Hydrochloride or Trabectedin in Treating Patients With Previously Untreated Advanced or Metastatic Soft Tissue SarcomaTerminatedNCT01189253Phase 2/3
- Doxorubicin vs. Trabectedin Plus Doxorubicin in Non Operable and/or Metastatic STSTerminatedNCT01104298Phase 2
- An Efficacy Study of Trabectedin in the Treatment of Participants With Specific Subtypes of Metastatic Breast CancerCompletedNCT00580112Phase 2
- A Phase 2 Study of Trabectedin (Yondelis) in Adult Male Participants With Advanced Prostate CancerCompletedNCT00072670Phase 2
- Phase 2 Study of ET-743 (Trabectedin) in Patients With Persistent or Recurrent Endometrial CarcinomaCompletedNCT00050440Phase 2
- A Study of ET-743 (Trabectedin) in Patients With Advanced Breast CancerCompletedNCT00050427Phase 2
- A Study of Trabectedin in Patients With Advanced Ovarian CancerCompletedNCT00050414Phase 2
- Ecteinascidin 743 in Treating Patients With Malignant MesotheliomaTerminatedNCT00027508Phase 2
- Ecteinascidin 743 in Treating Patients With Unresectable Advanced or Metastatic Soft Tissue SarcomaCompletedNCT00017030Phase 2
- Ecteinascidin 743 in Treating Children With Refractory Solid TumorsCompletedNCT00006463Phase 1
- Ecteinascidin 743 in Treating Patients With Previously Treated Metastatic OsteosarcomaCompletedNCT00005625Phase 2
- Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue SarcomaCompletedNCT00003939Phase 2
- Ecteinascidin 743 in Treating Adults With Advanced Solid TumorsCompletedNCT00002904Phase 1